SUGAR LAND, Texas--(BUSINESS WIRE)--Non-profit research organization Hope Biosciences Stem Cell Research Foundation (HBSCRF) has received FDA authorization for a randomized, double-blind, single center, Phase II clinical trial to assess the efficacy of multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells in improving symptoms and quality of life in patients with mild-to-moderate multiple sclerosis (MS). Read more →
top of page
Recent Posts
See AllHoustonians may have heard of Float Baby, an upscale water class in West University Place, or seen founder Kristi Ison on Season 7 of "Shark Tank." Back in 2016, she appeared on the hit television sho
Public safety K9s are known to help protect and serve their communities, along with their law enforcement partners. Read more.
Many Houstonians might know Houston designer Christina Greene for her striking combination of gold and turquoise jewelry. What they might not know is that she credits the Houston Livestock Show and Ro
bottom of page